Definitive Contract 36C24E18C0077

Award Date 9/24/18
Potential Completion Date 9/23/20
Potential Value $113K
Contracting Federal Agency
Veterans Integrated Service Network 4
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 2 awarded a $128,250.00 firm fixed price definitive contract for sequencing services to the New York Genome Center, Inc. (Nygc), a nonprofit academic research institution. This contract was awarded without a set-aside designation on September 24, 2018 and has a completion date of March 23, 2020. The original solicitation, a Special Notice, indicated the VA intended to sole source the...
This is a federal contract award to the New York Genome Center, Inc. (Nygc), a non-profit academic research institution, by the Department of Veterans Affairs (VA). The contract is for next-generation sequencing services to support an ongoing research study. The contract has a ceiling value of $22,762.00 and a period of performance through November 30, 2025. Nygc has supported various federal agencies and institutes, including the VA, National Institutes of Health (NIH), National Cancer...
This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs to the New York Genome Center (NYGC), a nonprofit academic research institution, to provide genome sequencing services in support of research. The $89,300 award supports NYGC's continued sequencing work for a VA study characterizing gene expression changes in amyotrophic lateral sclerosis (ALS). The contract does not have a set-aside designation,...
This is a $61,697.50 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 2 to the nonprofit New York Genome Center, Inc. (doing business as Nygc) for sequencing services. The award does not have a set-aside designation. Nygc is a leading academic research institution that specializes in genomic sequencing, analysis, and computational services for federal agencies. It has delivered these services to various NIH institutes as well...
This is a $68,058 firm-fixed-price purchase order awarded to New York Genome Center, Inc. (NYGC) by the Veterans Integrated Service Network 2, a civilian agency of the Department of Veterans Affairs. The contract is for sequencing services in support of research studies conducted by the VA James J. Peters VA Medical Center in Bronx, NY. The award was made on a sole-source basis under FAR 6.302-1, as the sequencing services must be provided by a vendor within a one-hour drive of the VA facility...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $54,397 delivery order contract to New York Genome Center, Inc. (doing business as Nygc) for next generation sequencing services in support of an ongoing research study. Nygc will provide sequencing at its New York, NY location under the firm fixed price contract, which runs from December 1, 2023 through November 30, 2024. No subcontractors or set aside designations were...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 has awarded a $82,720 firm fixed price delivery order contract to New York Genome Center, Inc. for next generation sequencing services to support an ongoing research study. The contract has no set-aside designation and requires the sequencing services be performed in New York, NY by December 4, 2023. As the award is associated with research being conducted by VHA, it can be inferred the...
This is a federal contract award to New York Genome Center, Inc. (Nygc), a nonprofit academic research institution, by the National Institute of Mental Health (NIMH), a civilian agency. The $73,817,033 contract is a delivery order under the BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core master IDIQ, which Nygc holds. Under this contract, Nygc will provide specialized genomic sequencing and analysis services to support major federal biomedical research initiatives. The contract...
This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
This is a firm fixed-price delivery order awarded by the National Institute of Mental Health (NIMH) to the New York Genome Center, Inc. (NYGC) for Task Area 1: Manual of Operations under the Brain Initiative Cell Atlas Network (BICAN) Sequencing Core contracts. The contract has a ceiling value of $38,000.00 and an ultimate completion date of May 13, 2025. NYGC, a non-profit academic research institution, will provide specialized genomic sequencing and analysis services to support the BRAIN...

This is a $112,860 definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for sequencing services to support the VA's research study on "Epigenetic Mechanisms in Blast Related Traumatic Brain Injury". NYGC has previously performed this work and the VA determined that continuing with NYGC is essential to avoid batch effects and maintain data consistency across multiple sample batches. The contract does not have a set-aside designation, reflecting the specialized nature of the genomic sequencing and analysis services provided by NYGC. NYGC often works as both a prime contractor and subcontractor on federal research contracts and grants, collaborating with academic partners to advance genomics research, particularly in areas like neurodegenerative diseases, neuropsychiatric disorders, and cancer.

Generated 3/19/25, 9:55 AM